Alaunos Therapeutics's total assets for Q2 2025 were $4.74M, an increase of 123.35% from the previous quarter. TCRT total liabilities were $1.07M for the fiscal quarter, a 1.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.